BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36123378)

  • 21. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
    Nguyen VHL; Hough R; Bernaudo S; Peng C
    J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Wnt3a/β-catenin/TCF7L2 signaling axis reduces the sensitivity of HER2-positive epithelial ovarian cancer to trastuzumab.
    Shen G; Gao Q; Liu F; Zhang Y; Dai M; Zhao T; Cheng M; Xu T; Jin P; Yin W; Huang D; Weng H; Chen W; Ren H; Mu X; Wu X; Hu S
    Biochem Biophys Res Commun; 2020 Jun; 526(3):685-691. PubMed ID: 32248976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT1-Induced Upregulation lncRNA LINC00958 Accelerates the Epithelial Ovarian Cancer Tumorigenesis by Regulating Wnt/
    Xie M; Fu Q; Wang PP; Cui YL
    Dis Markers; 2021; 2021():1405045. PubMed ID: 34790276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of long noncoding RNA HOXB-AS3 indicates an unfavorable prognosis and promotes tumorigenesis in epithelial ovarian cancer via Wnt/β-catenin signaling pathway.
    Zhuang XH; Liu Y; Li JL
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31337688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twist1 mediates repression of chondrogenesis by β-catenin to promote cranial bone progenitor specification.
    Goodnough LH; Chang AT; Treloar C; Yang J; Scacheri PC; Atit RP
    Development; 2012 Dec; 139(23):4428-38. PubMed ID: 23095887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling.
    Rosanò L; Cianfrocca R; Tocci P; Spinella F; Di Castro V; Spadaro F; Salvati E; Biroccio AM; Natali PG; Bagnato A
    Oncogene; 2013 Oct; 32(42):5066-77. PubMed ID: 23208497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic modifications in ovarian cancer stem cells following Paclitaxel treatment.
    Craveiro V; Yang-Hartwich Y; Holmberg JC; Joo WD; Sumi NJ; Pizzonia J; Griffin B; Gill SK; Silasi DA; Azodi M; Rutherford T; Alvero AB; Mor G
    Cancer Med; 2013 Dec; 2(6):751-62. PubMed ID: 24403249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway.
    Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression of TWIST1 and ZBTB16 is regulated by methylation modifications during the osteoblastic differentiation of mesenchymal stem cells.
    Marofi F; Vahedi G; Solali S; Alivand M; Salarinasab S; Zadi Heydarabad M; Farshdousti Hagh M
    J Cell Physiol; 2019 May; 234(5):6230-6243. PubMed ID: 30246336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
    Zhang Y; Dun Y; Zhou S; Huang XH
    Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
    Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y
    Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence.
    Chefetz I; Alvero AB; Holmberg JC; Lebowitz N; Craveiro V; Yang-Hartwich Y; Yin G; Squillace L; Gurrea Soteras M; Aldo P; Mor G
    Cell Cycle; 2013 Feb; 12(3):511-21. PubMed ID: 23324344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.
    Hu C; Dong T; Li R; Lu J; Wei X; Liu P
    Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential.
    Li J; Alvero AB; Nuti S; Tedja R; Roberts CM; Pitruzzello M; Li Y; Xiao Q; Zhang S; Gan Y; Wu X; Mor G; Yin G
    Oncogene; 2020 May; 39(20):3965-3979. PubMed ID: 32205869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.
    Yin G; Chen R; Alvero AB; Fu HH; Holmberg J; Glackin C; Rutherford T; Mor G
    Oncogene; 2010 Jun; 29(24):3545-53. PubMed ID: 20400975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer.
    Galván JA; Helbling M; Koelzer VH; Tschan MP; Berger MD; Hädrich M; Schnüriger B; Karamitopoulou E; Dawson H; Inderbitzin D; Lugli A; Zlobec I
    Oncotarget; 2015 Jan; 6(2):874-85. PubMed ID: 25528769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells.
    Lin HW; Chiang YC; Sun NY; Chen YL; Chang CF; Tai YJ; Chen CA; Cheng WF
    Endocr Relat Cancer; 2019 Jan; 26(1):73-88. PubMed ID: 30121622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The FZD7-TWIST1 axis is responsible for anoikis resistance and tumorigenesis in ovarian carcinoma.
    Tan M; Asad M; Heong V; Wong MK; Tan TZ; Ye J; Kuay KT; Thiery JP; Scott C; Huang RY
    Mol Oncol; 2019 Apr; 13(4):757-780. PubMed ID: 30548372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.